Allergic Rhinitis Market Size, Share, Growth Analysis, By Type(Seasonal Allergic Rhinitis (SAR), Perennial Allergic Rhinitis (PAR)), By Drug Class(Antihistamines, Corticosteroids, Decongestants, Leukotriene Inhibitors), By Distribution channel(Hospitals, Retail Pharmacies, and Online Pharmacies), By Route of Administrator(Oral, Parenteral, Intranasal), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2216 | Region: Global | Published Date: June, 2024
Pages: 219 |Tables: 118 |Figures: 77

Allergic Rhinitis Market Insights

Global Allergic Rhinitis Market size was valued at USD 12 Billion in 2022 and is poised to grow from USD 12.42 Billion in 2023 to USD 16.35 Billion by 2031, at a CAGR of 3.5% during the forecast period (2024-2031).

The allergic rhinitis marketplace is inspired via factors inclusive of the increasing occurrence of allergic disorders, converting environmental conditions, and a growing cognizance of remedy options. Key drivers include the improvement of novel therapeutics, a upward thrust in healthcare expenditure, and ongoing studies for more powerful treatments. However, demanding situations consist of the supply of over-the-counter medications impacting prescription income. The market is characterized through the presence of most important pharmaceutical corporations and a focus on developing immunotherapy answers. Continuous improvements in remedy modalities and a personalized medication method are high-quality tendencies shaping the allergic rhinitis market.

Market Snapshot - 2024-2031

Global Market Size

USD 12 Billion

Largest Segment

Intranasal Corticosteroids

Fastest Growth

Intranasal Corticosteroids

Growth Rate

3.5% CAGR

Allergic Rhinitis Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Allergic Rhinitis Market Segmental Analysis

The global allergic rhinitis market is segmented into type, drug class, route of administrator, distribution channel and region. Based on type, the market is segmented into Seasonal Allergic Rhinitisc and Perennial Allergic Rhinitis. Based on drug class, the market is segmented into Antihistamines, intranasal corticosteroids, immunotherapies. Based on route of administrator, the market is segmented into oral, parenteral, and intranasal. Based on distribution channel, the market is segmented into hospitals, retail pharmacies, online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 

Analysis by Treatment Modalities 

Intranasal Corticosteroids have typically held a widespread market proportion as Corticosteroids, whether or not nasal sprays or oral medicines, are frequently taken into consideration fantastically powerful in managing allergic rhinitis symptoms. They cope with infection and provide comprehensive alleviation, making them a dominant desire, particularly for slight to excessive cases. 

Immunotherapy, in particular subcutaneous and sublingual forms, is gaining traction because of its capability to regulate the underlying immune reaction, offering lengthy-term remedy. As focus grows and extra centered immunotherapy alternatives become to be had, this modality is expected to be most of the fastest-developing. 

Analysis by Type 

SAR is frequently dominant because of its affiliation with unique allergens like pollen all through sure seasons. The predictable nature of triggers allows for centered treatment techniques, making SAR a common cognizance for both patients and healthcare companies. 

PAR, induced by using yr-round allergens which include dust mites, animal dander, and mould, might also see extended interest because of its chronic nature. As attention grows about non-seasonal triggers and their impact on each day life, PAR can be the fastest-developing type.

Allergic Rhinitis Market By Drug Class

To get detailed analysis on other segments, Request For Free Sample Report

Allergic Rhinitis Market Regional Insights

North America, in particular the US, is expected to dominate the marketplace because of an excessive occurrence of allergic rhinitis, properly-established healthcare infrastructure, and a sturdy marketplace for prescription drugs. The region additionally has an excessive consciousness of allergic conditions and sizable investments in research and improvement.

Asia-Pacific, along with international locations like China and India, was expected to be the fastest-growing marketplace. Factors along with a large and getting older populace, converting existence, increasing urbanization, and a growing focus of allergic disorders make a contribution to the increase. Moreover, improvements in healthcare get admission to and a developing center elegance are anticipated to power demand for allergic rhinitis remedies.

Allergic Rhinitis Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Allergic Rhinitis Market Dynamics

Drivers

Increasing prevalence of allergic rhinitis worldwide

  • The increasing occurrence of allergic rhinitis internationally, driven via environmental factors and changing existence, underscores the growing call for powerful remedy alternatives. The upward thrust in urbanization, pollution ranges, and publicity to allergens plays a good sized position in the enlargement of the allergic rhinitis market.

Restraints

High Underdiagnosis And Undertreatment Of Allergic Rhinitis

  • One of the principal marketplace restraints is the underdiagnosis and undertreatment of allergic rhinitis, often stemming from a lack of awareness or misinterpretation of signs and symptoms through both patients and healthcare providers. Additionally, the provision and affordability of medicinal drugs, specially in growing regions, pose limitations to comprehensive management. Regulatory complexities, along with versions in approval strategies for hypersensitive reaction medications, can avert market expansion and the advent of novel treatment options.

Request Free Customization of this report to help us to meet your business objectives.

Allergic Rhinitis Market Competitive Landscape

The aggressive environment of the Allergic Rhinitis marketplace is dynamic and is characterized by using the presence of key pharmaceutical businesses striving for market proportion. The enterprise leaders continually put money into research and development to introduce innovative remedies, enhancing their aggressive positions.

Top Player’s Company Profiles

  • Bayer (Claritin, Allegra)
  • Johnson & Johnson (Zyrtec, Zyrtec-D)
  • Pfizer (Benadryl)
  • GlaxoSmithKline (Flonase, Avamys, Nasacort)
  • Merck & Co. (Singulair)
  • Sanofi (Allegra - partnered with Bayer)
  • Teva Pharmaceutical Industries (Flonase - partnered with GlaxoSmithKline)
  • Mylan Pharmaceuticals (Loratadine, Cetirizine)
  • Perrigo Company (Diphenhydramine, Cetirizine)
  • Boehringer Ingelheim (Rhinocort)
  • AstraZeneca (Nasacort - partnered with GlaxoSmithKline)
  • Sun Pharma Global (Montelukast, Cetirizine)
  • Almirall Laboratories (Azelastine)
  • Stallergenes Greer (allergen immunotherapy tablets)
  • Circassia Pharmaceuticals (Dulolorin)
  • Viatris (Levocetirizine)
  • Meda Pharmaceuticals (Mometasone furoate)
  • Dr. Reddy's Laboratories (Loratadine, Cetirizine)
  • Cipla (Fexofenadine, Levocetirizine)
  • Glenmark Pharmaceuticals (Montelukast, Desloratadine)

Recent Developments

  • May 2023: Bausch Health Companies Inc. (NYSE/TSX: BHC) has introduced the release of its prescription treatment, RYALTRIS® (olopatadine hydrochloride and mometasone furoate nasal spray), now to be had in Canada.
  • October 2023: Hikma Pharmaceuticals has released Ryaltris (olopatadine hydrochloride and mometasone furoate) nasal spray. Ryaltris is approved to deal with signs and symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older.

Allergic Rhinitis Key Market Trends

  • Rising Shift towards Precision Medicine And Personalized Treatment Approaches: The discernible shift in the direction of precision medicine and personalized treatment strategies, tailoring interventions primarily based on personal patient profiles and particular allergen sensitivities. Immunotherapy, especially sublingual and subcutaneous paperwork, is gaining prominence as an extended-time period solution offering ailment change.

Allergic Rhinitis Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

Global Allergic Rhinitis market evaluation reveals a dynamic marketplace with some of standout trends and difficulties. The marketplace is driven by a growing prevalence of allergic problems, environmental elements, and improvements in remedy options. However, demanding situations encompass underdiagnosis, regulatory complexities, and affordability issues. Antihistamines, corticosteroids, and immunotherapy dominate product sorts. North America leads due to consciousness and healthcare infrastructure. Asia-Pacific is the fastest-developing region with increasing urbanization. Key trends contain customized medicinal drugs, biologics improvement, and a developing emphasis on virtual fitness answers for complete allergic rhinitis control.

Report Metric Details
Market size value in 2022 USD 12 Billion
Market size value in 2031 USD 16.35 Billion
Growth Rate 3.5%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Seasonal Allergic Rhinitis (SAR), Perennial Allergic Rhinitis (PAR)
  • Drug Class
    • Antihistamines, Corticosteroids, Decongestants, Leukotriene Inhibitors, and Immunotherapy
  • Distribution channel
    • Hospitals, Retail Pharmacies, and Online Pharmacies
  • Route of Administrator
    • Oral, Parenteral, Intranasal
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Bayer (Claritin, Allegra)
  • Johnson & Johnson (Zyrtec, Zyrtec-D)
  • Pfizer (Benadryl)
  • GlaxoSmithKline (Flonase, Avamys, Nasacort)
  • Merck & Co. (Singulair)
  • Sanofi (Allegra - partnered with Bayer)
  • Teva Pharmaceutical Industries (Flonase - partnered with GlaxoSmithKline)
  • Mylan Pharmaceuticals (Loratadine, Cetirizine)
  • Perrigo Company (Diphenhydramine, Cetirizine)
  • Boehringer Ingelheim (Rhinocort)
  • AstraZeneca (Nasacort - partnered with GlaxoSmithKline)
  • Sun Pharma Global (Montelukast, Cetirizine)
  • Almirall Laboratories (Azelastine)
  • Stallergenes Greer (allergen immunotherapy tablets)
  • Circassia Pharmaceuticals (Dulolorin)
  • Viatris (Levocetirizine)
  • Meda Pharmaceuticals (Mometasone furoate)
  • Dr. Reddy's Laboratories (Loratadine, Cetirizine)
  • Cipla (Fexofenadine, Levocetirizine)
  • Glenmark Pharmaceuticals (Montelukast, Desloratadine)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Allergic Rhinitis Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Allergic Rhinitis Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Allergic Rhinitis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Allergic Rhinitis Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Allergic Rhinitis Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Allergic Rhinitis Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Allergic Rhinitis Market size was valued at USD 12 Billion in 2022 and is poised to grow from USD 12.42 Billion in 2023 to USD 16.35 Billion by 2031, at a CAGR of 3.5% during the forecast period (2024-2031).

The aggressive environment of the Allergic Rhinitis marketplace is dynamic and is characterized by using the presence of key pharmaceutical businesses striving for market proportion. The enterprise leaders continually put money into research and development to introduce innovative remedies, enhancing their aggressive positions. 'Bayer (Claritin, Allegra)', 'Johnson & Johnson (Zyrtec, Zyrtec-D)', 'Pfizer (Benadryl)', 'GlaxoSmithKline (Flonase, Avamys, Nasacort)', 'Merck & Co. (Singulair)', 'Sanofi (Allegra - partnered with Bayer)', 'Teva Pharmaceutical Industries (Flonase - partnered with GlaxoSmithKline)', 'Mylan Pharmaceuticals (Loratadine, Cetirizine)', 'Perrigo Company (Diphenhydramine, Cetirizine)', 'Boehringer Ingelheim (Rhinocort)', 'AstraZeneca (Nasacort - partnered with GlaxoSmithKline)', 'Sun Pharma Global (Montelukast, Cetirizine)', 'Almirall Laboratories (Azelastine)', 'Stallergenes Greer (allergen immunotherapy tablets)', 'Circassia Pharmaceuticals (Dulolorin)', 'Viatris (Levocetirizine)', 'Meda Pharmaceuticals (Mometasone furoate)', 'Dr. Reddy's Laboratories (Loratadine, Cetirizine)', 'Cipla (Fexofenadine, Levocetirizine)', 'Glenmark Pharmaceuticals (Montelukast, Desloratadine)'

The increasing occurrence of allergic rhinitis internationally, driven via environmental factors and changing existence, underscores the growing call for powerful remedy alternatives. The upward thrust in urbanization, pollution ranges, and publicity to allergens plays a good sized position in the enlargement of the allergic rhinitis market.

Rising Shift towards Precision Medicine And Personalized Treatment Approaches: The discernible shift in the direction of precision medicine and personalized treatment strategies, tailoring interventions primarily based on personal patient profiles and particular allergen sensitivities. Immunotherapy, especially sublingual and subcutaneous paperwork, is gaining prominence as an extended-time period solution offering ailment change.

North America, in particular the US, is expected to dominate the marketplace because of an excessive occurrence of allergic rhinitis, properly-established healthcare infrastructure, and a sturdy marketplace for prescription drugs. The region additionally has an excessive consciousness of allergic conditions and sizable investments in research and improvement.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Allergic Rhinitis Market

Report ID: SQMIG35D2216

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE